Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Clinical trial NCT03632759 · COMPLETED
Trial details
- NCT number
- NCT03632759
- Sponsor
- Carla Greenbaum, MD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2021-11-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.